Log In

 

Company Name : BERTIN

Thursday, May 18, 2017 10:30AM IST (5:00AM GMT)

(BW)(BERTIN)

Cryolys® Evolution: Embedded Cooling Module Designed for the Precellys® Evolution Homogenizer


A unique protection for thermo-sensitive samples preparation


Montigny-le-Bretonneux, France

On the occasion of Biotechnica, the international trade show for biotechnology and life sciences (Hannover, Germany, from May 16 to 18, 2017), BERTIN, subsidiary of CNIM Group, presents its latest generation of patented cooling module for Precellys® Evolution homogenizers: the Cryolys® Evolution. It enables to keep the temperature of the samples between 0°C and 10°C during homogenization preventing them from heat degradation.

 

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170517005929/en/

 

This new version of Cryolys® is installed on the top of Bertin’s Precellys® Evolution homogenizer without any air pipe or power cable – it is powered directly through the Precellys® unit. End-users may control both devices from a single interface, enabling them to benefit from greater performances in a smaller size.

 

Cryolys® Evolution allows preventing the degradation of thermo-sensitive molecules such as RNA, siRNA, metabolites, enzymes or proteins. These molecules are subject to more and more investigations, especially in the fields of Cancer Research and Pharmacology. Cryolys® Evolution’s patented technology allows to maintain a low temperature (0°C- 10°C) before, during and after the grinding process with Precellys® Evolution.

 

The Cryolys® technology is based on using air as a cooling media to cool down the tubes surrounding under the Precellys’® lid. The new Cryolys® Evolution is free standing and uses only dry ice and ambient air without frost generation, which is a major innovation. Moreover, Precellys® Evolution now completely drives the cooling unit through its software-integrated programming functions. Thereby, the accuracy and the efficiency of the system have been drastically improved, in order to offer the best thermo-sensitive molecules' protection from heat degradation during homogenization.

 

“Our Precellys® homogenizer has been a huge success for over 10 years to many lab handling biological samples” comments Bruno Vallayer, PhD, Vice President Marketing & Sales Bertin Technologies. “But those who wished to use it in combination with our previous cooling option had to ensure they could have access to compressed-air network – which was not always the case. This new version of Cryolys® will enable them to get rid of this constraint. It will also be quite handy for facilities dealing with limited space or safety constraints such as Bio Safety Laboratories”.

 

Find out more on Cryolys Evolution

 

 

 

 

 

 
MULTIMEDIA AVAILABLE :
http://www.businesswire.com/news/home/20170517005929/en/


Click here for Media Contact Details
CONTACTS : PressFor BertinFrédérique Vigezzi, Tel: +33 (0)143 59 29 84frederique.vigezzi@gootenberg.fr

More News from BERTIN

30/09/2016 11:33AM

BERTIN Launches the Latest AlphaGUARD Radon Gas Measurement Solution

BERTIN, entity of CNIM Group, is pleased to present the latest version of its AlphaGUARD radon measurement solution (developed with Saphymo’s expertise). This portable equipment is re-designed for instantaneous or ...

29/09/2016 2:30PM

InCellis: The New Age of Cell Imaging by BERTIN

BERTIN, entity of CNIM Group, is launching InCellis, a new cell imager developed to provide high quality images and facilitate the scientists’ day to day manipulation. The image quality in brightfield, phase ...

09/06/2016 2:52PM

FUSIONSIGHT®: BERTIN Launches the World-First Digital Night Vision Device Providing Smart Fusion for Threat and Target Accurate Detection

BERTIN, a brand of CNIM Group, is pleased to present its new FusionSight® Night Vision Device during Eurosatory 2016, held from June 13 to 17 in Paris, France. Developed in partnership with PHOTONIS, ...

Similar News

21/07/2017 7:50PM

Janssen Receives Positive CHMP Opinion for SYMTUZA™ The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV

Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing ...

No Image

21/07/2017 6:50PM Image

TransDisciplinary University Brings Together the Best Minds to Deliberate over the Promise and Problems of Synthetic Biology

The TransDisciplinary University (TDU), in collaboration with the United Nations Environment and the UN Convention on Biological Diversity (CBD), has kick-started a four-part seminar series of science-policy-practice ...